Nocturnal hypoxemia biomarker predicts sleepiness in patients with severe obstructive sleep apnea.

PURPOSE: This study aims to assess the association between excessive daytime sleepiness (EDS) and variables extracted from the pulse-oximetry signal obtained during overnight polysomnography. METHODS: A cross-sectional design was used to study the relation between four hypoxemia variables and EDS as determined by Epworth Sleepiness Scale scores (ESSS) in 200 consecutive patients, newly diagnosed with obstructive sleep apnea (OSA), as defined by an apnea-hypopnea index (AHI)≥ 15. Hypoxemia measurements were compared between sleepy (ESSS ≥ 10) and nonsleepy (ESSS<10) patients before and after dichotomizing the cohort for each hypoxemia variable (and for AHI) such that there were 35 (165) patients in each of the corresponding higher (lower) subcohorts. The hypoxemia variables were combined into a biomarker, and its accuracy for predicting sleepiness in individual patients was evaluated. We planned to interpret prediction accuracy above 80 % as evidence that hypoxemia predicted EDS. RESULTS: Hypoxemia was unassociated with sleepiness in OSA patients with AHI in the range of 15 to 50. In patients with AHI>50, the hypoxemia biomarker (but not individual hypoxemia variables) predicted sleepiness with 82 % accuracy. CONCLUSION: Nocturnal hypoxemia as determined by a polyvariable biomarker reliably predicted EDS in patients with severe OSA (AHI>50), indicating that oxygen fluctuation had a direct role in the development of EDS in patients with severe OSA.

Electromagnetic hypersensitivity: evidence for a novel neurological syndrome.

OBJECTIVE: We sought direct evidence that acute exposure to environmental-strength electromagnetic fields (EMFs) could induce somatic reactions (EMF hypersensitivity). METHODS: The subject, a female physician self-diagnosed with EMF hypersensitivity, was exposed to an average (over the head) 60-Hz electric field of 300 V/m (comparable with typical environmental-strength EMFs) during controlled provocation and behavioral studies. RESULTS: In a double-blinded EMF provocation procedure specifically designed to minimize unintentional sensory cues, the subject developed temporal pain, headache, muscle twitching, and skipped heartbeats within 100 s after initiation of EMF exposure (p < .05). The symptoms were caused primarily by field transitions (off-on, on-off) rather than the presence of the field, as assessed by comparing the frequency and severity of the effects of pulsed and continuous fields in relation to sham exposure. The subject had no conscious perception of the field as judged by her inability to report its presence more often than in the sham control. DISCUSSION: The subject demonstrated statistically reliable somatic reactions in response to exposure to subliminal EMFs under conditions that reasonably excluded a causative role for psychological processes. CONCLUSION: EMF hypersensitivity can occur as a bona fide environmentally inducible neurological syndrome.

Simulated MR magnetic field induces steady-state changes in brain dynamics: Implications for interpretation of functional MR studies.

We examined whether a magnetic field comparable to one of the fields produced during MRI induced steady-state changes in brain electrical activity while the field was applied (called a presence effect to distinguish it from evoked potentials). The electroencephalogram was measured from standard scalp locations in the presence and absence of 100-200 microT, 60 Hz, and the effect of the field was evaluated by nonlinear (recurrence analysis) and linear techniques; individual subjects served as their own controls. Using recurrence analysis, changes in brain activity lasting 1 sec (the longest interval considered) were found in 21 of 22 subjects (P < 0.05 for each subject). The presence effect was not detected using linear analysis and was reversible, as indicated by a return of brain activity to baseline levels in all subjects within 2 sec of field offset. The possible role of artifacts or systematic errors was ruled out by studies using electrical phantoms and by analyses of electroencephalograms recorded during sham exposure. It is reasonable to expect that actual scanner magnetic fields also produce nonlinear steady-state perturbations of brain dynamical activity. The effect may influence the picture of brain connectivity inferred in some functional MR studies.

Evidence that transduction of electromagnetic field is mediated by a force receptor.

Low-strength magnetic fields triggered onset and offset evoked potentials, indicating that the detection process was a form of sensory transduction; whether the field interacted directly with an ion channel or indirectly via a signaling cascade is unknown. By analogy with electrosensory transduction in lower life forms, we hypothesized that the evoked potentials were initiated by a force exerted by the induced electric field on an ion channel in the plasma membrane. We applied a rapid magnetic stimulus (0.2 ms) and found that it produced evoked potentials indistinguishable in latency, magnitude, and frequency from those found previously when the stimulus was 50 times slower. The ability of the field-detection system in human subjects to respond to the rapid stimulus supported the theory that the receptor potentials necessary for production of evoked potentials originated from a direct interaction between the field and an ion channel in the plasma membrane that resulted in a change in the average probability of the channel to be in the open state.

The electric field is a sufficient physical determinant of the human magnetic sense.

PURPOSE: The onset and offset of weak low-frequency magnetic fields triggered evoked potentials in human subjects that could be detected using nonlinear analysis, but not by means of time averaging. Because the magnetic fields and their induced electric fields were both present in the brain, their respective role in producing the effect on brain activity could not be ascertained. We inquired whether a biophysical coupling mechanism involving only the electric field could explain the occurrence of the brain potentials. MATERIALS AND METHODS: An external electric field capable of producing a brain electric field comparable to that induced by the magnetic stimuli was identified by finite-element analysis. The electroencephalogram from 23 subjects was measured from six scalp derivations in the presence and absence of the external electric field, and the presence of evoked potentials was assessed using nonlinear and linear analyses. RESULTS: Evoked potentials were observed in all but one subject (p < 0.05 in each subject); the potentials had the same latency, duration, and distribution of magnitudes as seen in the earlier studies, and were detectable only by means of nonlinear analysis. Using a realistic physical model of an ion channel, we showed that transduction of an electric field could be explained by assuming that the field exerted a force on glycocalyx molecules attached to a channel gate. CONCLUSION: The evoked potentials described here, as well as those observed previously in response to magnetic stimuli, were probably triggered by the induced electric field.

Practice parameters for the use of autotitrating continuous positive airway pressure devices for titrating pressures and treating adult patients with obstructive sleep apnea syndrome: an update for 2007. An American Academy of Sleep Medicine report.

These practice parameters are an update of the previously published recommendations regarding the use of autotitrating positive airway pressure (APAP) devices for titrating pressures and treating adult patients with obstructive sleep apnea syndrome. Continuous positive airway pressure (CPAP) at an effective setting verified by attended polysomnography is a standard treatment for obstructive sleep apnea (OSA). APAP devices change the treatment pressure based on feedback from various patient measures such as airflow, pressure fluctuations, or measures of airway resistance. These devices may aid in the pressure titration process, address possible changes in pressure requirements throughout a given night and from night to night, aid in treatment of OSA when attended CPAP titration has not or cannot be accomplished, or improve patient comfort. A task force of the Standards of Practice Committee of the American Academy of Sleep Medicine has reviewed the literature published since the 2002 practice parameter on the use of APAP. Current recommendations follow: (1) APAP devices are not recommended to diagnose OSA; (2) patients with congestive heart failure, patients with significant lung disease such as chronic obstructive pulmonary disease; patients expected to have nocturnal arterial oxyhemoglobin desaturation due to conditions other than OSA (e.g., obesity hypoventilation syndrome); patients who do not snore (either naturally or as a result of palate surgery); and patients who have central sleep apnea syndromes are not currently candidates for APAP titration or treatment; (3) APAP devices are not currently recommended for split-night titration; (4) certain APAP devices may be used during attended titration with polysomnography to identify a single pressure for use with standard CPAP for treatment of moderate to severe OSA; (5) certain APAP devices may be initiated and used in the self-adjusting mode for unattended treatment of patients with moderate to severe OSA without significant comorbidities (CHF, COPD, central sleep apnea syndromes, or hypoventilation syndromes); (6) certain APAP devices may be used in an unattended way to determine a fixed CPAP treatment pressure for patients with moderate to severe OSA without significant comorbidities (CHF, COPD, central sleep apnea syndromes, or hypoventilation syndromes); (7) patients being treated with fixed CPAP on the basis of APAP titration or being treated with APAP must have close clinical follow-up to determine treatment effectiveness and safety; and (8) a reevaluation and, if necessary, a standard attended CPAP titration should be performed if symptoms do not resolve or the APAP treatment otherwise appears to lack efficacy.

Magnetosensory evoked potentials: consistent nonlinear phenomena.

Electromagnetic fields (EMFs) having strengths typically found in the general environment can alter brain activity, but the reported effects have been inconsistent. We theorized that the problem arose from the use of linear methods for analyzing what were actually nonlinear phenomena, and therefore studied whether the nonlinear signal-processing technique known as recurrence quantification analysis (RQA) could be employed as the basis of a reliable method for demonstrating consistent changes in brain activity. Our primary purpose was to develop such a method for observing the occurrence of evoked potentials in individual subjects exposed to magnetic fields (2G, 30 and 60 Hz). After all conditions that affected the analysis of the EEG were specified in advance, we detected magnetosensory evoked potentials (MEPs) in all 15 subjects (P<0.05 in each experiment). The MEPs, which occurred within the predicted latency interval of 109-504 ms, were independent of the frequency and the direction of the field, and were not detected using the traditional linear method of analysis, time averaging. When the results obtained within subjects were averaged across subjects, the evoked potentials could not be detected, indicating how real nonlinear phenomena can be averaged away when the incorrect method of analysis is used. Recurrence quantification analysis, but not linear analysis, permitted consistent demonstration of MEPs. The use of nonlinear analysis might also resolve apparent inconsistencies in other kinds of brain studies.

Method for detection of changes in the EEG induced by the presence of sensory stimuli.

The onset and offset of sensory stimuli evoke transient changes in the electroencephalogram (EEG) that can be detected by linear and/or nonlinear analysis. However, there is presently no systematic procedure to quantify the brain-electrical-activity correlate of the presence of a stimulus (as opposed to its onset evoked potential). We describe a method for detecting a stimulus-related change in brain electrical activity that persists while the stimulus is present (presence effect). The method, which is based on phase-space embedding of the EEG time series followed by quantitative analysis of the recurrence plot of the embedded signal, was used to demonstrate the occurrence of a presence effect in separate groups of human subjects exposed to sound, a magnetic field, and light. Any form of law-governed dynamical activity induced in the EEG can be detected, particularly activity that is nonlinearly related to the stimulus. Salient mathematical features of the method were reproduced in a model EEG system containing known nonlinear determinism.

Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American Academy of Sleep Medicine report.

The expanding science of circadian rhythm biology and a growing literature in human clinical research on circadian rhythm sleep disorders (CRSDs) prompted the American Academy of Sleep Medicine (AASM) to convene a task force of experts to write a review of this important topic. Due to the extensive nature of the disorders covered, the review was written in two sections. The first review paper, in addition to providing a general introduction to circadian biology, addresses "exogenous" circadian rhythm sleep disorders, including shift work disorder (SWD) and jet lag disorder (JLD). The second review paper addresses the "endogenous" circadian rhythm sleep disorders, including advanced sleep phase disorder (ASPD), delayed sleep phase disorder (DSPD), irregular sleep-wake rhythm (ISWR), and the non-24-hour sleep-wake syndrome (nonentrained type) or free-running disorder (FRD). These practice parameters were developed by the Standards of Practice Committee and reviewed and approved by the Board of Directors of the AASM to present recommendations for the assessment and treatment of CRSDs based on the two accompanying comprehensive reviews. The main diagnostic tools considered include sleep logs, actigraphy, the Morningness-Eveningness Questionnaire (MEQ), circadian phase markers, and polysomnography. Use of a sleep log or diary is indicated in the assessment of patients with a suspected circadian rhythm sleep disorder (Guideline). Actigraphy is indicated to assist in evaluation of patients suspected of circadian rhythm disorders (strength of recommendation varies from "Option" to "Guideline," depending on the suspected CRSD). Polysomnography is not routinely indicated for the diagnosis of CRSDs, but may be indicated to rule out another primary sleep disorder (Standard). There is insufficient evidence to justify the use of MEQ for the routine clinical evaluation of CRSDs (Option). Circadian phase markers are useful to determine circadian phase and confirm the diagnosis of FRD in sighted and unsighted patients but there is insufficient evidence to recommend their routine use in the diagnosis of SWD, JLD, ASPD, DSPD, or ISWR (Option). Additionally, actigraphy is useful as an outcome measure in evaluating the response to treatment for CRSDs (Guideline). A range of therapeutic interventions were considered including planned sleep schedules, timed light exposure, timed melatonin doses, hypnotics, stimulants, and alerting agents. Planned or prescribed sleep schedules are indicated in SWD (Standard) and in JLD, DSPD, ASPD, ISWR (excluding elderly-demented/nursing home residents), and FRD (Option). Specifically dosed and timed light exposure is indicated for each of the circadian disorders with variable success (Option). Timed melatonin administration is indicated for JLD (Standard); SWD, DSPD, and FRD in unsighted persons (Guideline); and for ASPD, FRD in sighted individuals, and for ISWR in children with moderate to severe psychomotor retardation (Option). Hypnotic medications may be indicated to promote or improve daytime sleep among night shift workers (Guideline) and to treat jet lag-induced insomnia (Option). Stimulants may be indicated to improve alertness in JLD and SWD (Option) but may have risks that must be weighed prior to use. Modafinil may be indicated to improve alertness during the night shift for patients with SWD (Guideline).

Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin.

These practice parameters pertain to the treatment of hypersomnias of central origin. They serve as both an update of previous practice parameters for the therapy of narcolepsy and as the first practice parameters to address treatment of other hypersomnias of central origin. They are based on evidence analyzed in the accompanying review paper. The specific disorders addressed by these parameters are narcolepsy (with cataplexy, without cataplexy, due to medical condition and unspecified), idiopathic hypersomnia (with long sleep time and without long sleep time), recurrent hypersomnia and hypersomnia due to medical condition. Successful treatment of hypersomnia of central origin requires an accurate diagnosis, individual tailoring of therapy to produce the fullest possible return of normal function, and regular follow-up to monitor response to treatment. Modafinil, sodium oxybate, amphetamine, methamphetamine, dextroamphetamine, methylphenidate, and selegiline are effective treatments for excessive sleepiness associated with narcolepsy, while tricyclic antidepressants and fluoxetine are effective treatments for cataplexy, sleep paralysis, and hypnagogic hallucinations; but the quality of published clinical evidence supporting them varies. Scheduled naps can be beneficial to combat sleepiness in narcolepsy patients. Based on available evidence, modafinil is an effective therapy for sleepiness due to idiopathic hypersomnia, Parkinson's disease, myotonic dystrophy, and multiple sclerosis. Based on evidence and/or long history of use in the therapy of narcolepsy committee consensus was that modafinil, amphetamine, methamphetamine, dextroamphetamine, and methylphenidate are reasonable options for the therapy of hypersomnias of central origin.

Nonlinear EEG activation evoked by low-strength low-frequency magnetic fields.

Recent electrophysiological evidence suggested the existence of a human magnetic sense, but the kind of dynamical law that governed the stimulus-response relationship was not established. We tested the hypothesis that brain potentials evoked by the onset of a weak, low-frequency magnetic field were nonlinearly related to the stimulus. A field of 1G, 60 Hz was applied for 2s, with a 5s inter-stimulus period, and brain potentials were recorded from occipital electrodes in eight subjects, each of whom were measured twice, with at least 1 week between measurements. The recorded signals were subjected to nonlinear (recurrence analysis) and linear (time averaging) analyses. Using recurrence analysis, magnetosensory evoked potentials (MEPs) were detected in each subject in both the initial and replicate studies, with one exception. All MEPs exhibited the expected latency but differed in dynamical characteristics, indicating that they were nonlinearly related to the stimulus. MEPs were not detected using time averaging, thereby further confirming their nonlinearity. Evolutionarily conditioned structures that help mediate linear field-transduction in lower life forms may be expressed and functionally utilized in humans, but in a role where they facilitate vulnerability to man-made environmental fields.

The Fingerprint of Rapid Eye Movement: Its Algorithmic Detection in the Sleep Electroencephalogram Using a Single Derivation.

The strong associations of rapid eye movement (REM) sleep with dreaming and memory consolidation imply the existence of REM-specific brain electrical activity, notwithstanding the visual similarity of the electroencephalograms (EEGs) in REM and wake states. Our goal was to detect REM sleep by means of algorithmic analysis of the EEG. We postulated that novel depth and fragmentation variables, defined in relation to temporal changes in the signal (recurrences), could be statistically combined to allow disambiguation of REM epochs. The cohorts studied were consecutive patients with obstructive sleep apnea (OSA) recruited from a sleep medicine clinic, and clinically normal participants selected randomly from a national database (N = 20 in each cohort). Individual discriminant analyses were performed, for each subject based on 4 recurrence biomarkers, and used to classify every 30-second epoch in the subject's overnight polysomnogram as REM or NotREM (wake or any non-REM sleep stage), using standard clinical staging as ground truth. The primary outcome variable was the accuracy of algorithmic REM classification. Average accuracies of 90% and 87% (initial and cross-validation analyses) were achieved in the OSA cohort; corresponding results in the normal cohort were 87% and 85%. Analysis of brain recurrence allowed identification of REM sleep, disambiguated from wake and all other stages, using only a single EEG lead, in subjects with or without OSA.

Continuous Positive Airway Pressure Device Time to Procurement in a Disadvantaged Population.

Introduction. The management of obstructive sleep apnea (OSA) in patients who cannot afford a continuous positive airway pressure (CPAP) device is challenging. In this study we compare time to CPAP procurement in three groups of patients diagnosed with OSA: uninsured subsidized by a humanitarian grant (Group 1), uninsured unsubsidized (Group 2), and those with Medicare or Medicaid (Group 3). We evaluate follow-up and adherence in Group 1. We hypothesize that additional factors, rather than just the ability to obtain CPAP, may uniquely affect follow-up and adherence in uninsured patients. Methods. 30 patients were in Groups 1 and 2, respectively. 12 patients were in Group 3. Time of CPAP procurement from OSA diagnosis to CPAP initiation was assessed in all groups. CPAP adherence data was collected for Group 1 patients at 1, 3, 6, and 9 months. Results. There were no significant differences between groups in gender, age, body mass index, or apnea hypopnea index. The mean time to procurement in Group 1 was shorter compared to Group 2 but not significant. Compared to both Group 1 and Group 2, Group 3 patients had significantly shorter times to device procurement. Conclusion. Time to procurement of CPAP was significantly shorter in those with Medicaid/Medicare insurance compared to the uninsured.

A pilot study: portable out-of-center sleep testing as an early sleep apnea screening tool in acute ischemic stroke.

INTRODUCTION: Prompt diagnosis of obstructive sleep apnea (OSA) after acute ischemic stroke (AIS) is critical for optimal clinical outcomes, but in-laboratory conventional polysomnograms (PSG) are not routinely practical. Though portable out-of-center type III cardiopulmonary sleep studies (out-of-center cardiopulmonary sleep testing [OCST]) are widely available, these studies have not been validated in patients who have recently suffered from AIS. We hypothesized that OCST in patients with AIS would yield similar results when compared to conventional PSG. METHODS: Patients with AIS had simultaneous type III OCST and PSG studies performed within 72 hours from symptom onset. The accuracy of OCST was compared to PSG using: chi-square tests, receiver operatory characteristic curves, Bland-Altman plot, paired Student's t-test/Wilcoxon signed-rank test, and calculation of sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). RESULTS: Twenty-one out of 23 subjects with AIS (age 61±9.4 years; 52% male; 58% African-American) successfully completed both studies (9% technical failure). Nearly all (95%) had Mallampati IV posterior oropharynx; the mean neck circumference was 16.8±1.6 in. and the mean body mass index (BMI) was 30±7 kg/m(2). The apnea hypopnea index (AHI) provided by OCST was similar to that provided by PSG (19.8±18.0 vs 22.0±22.7, respectively; P=0.49). On identifying subjects by OCST with an AHI ≥5 on PSG, OCST had the following parameters: sensitivity 100%, specificity 85.7%, PPV 93%, and NPV 100%. On identifying subjects with an AHI ≥15 on PSG, OCST parameters were as follows: sensitivity 100%, specificity 83.3%, PPV 81.8%, and NPV 100%. Bland-Altman plotting showed an overall diagnostic agreement between OCST and PSG modalities for an AHI cutoff >5, despite fine-grained differences in estimated AHIs. CONCLUSION: Compared with PSG, OCST provides similar diagnostic information when run simultaneously in AIS patients. OCST is a reliable screening tool for early diagnosis of OSA in AIS patients.

Practice parameters for the use of portable monitoring devices in the investigation of suspected obstructive sleep apnea in adults.

BACKGROUND: A variety of devices are used to evaluate patients with a potential diagnosis of obstructive sleep apnea (OSA). A committee comprised of members of the American Academy of Sleep Medicine, American Thoracic Society, and American College of Chest Physicians systematically evaluated data on the use of these devices and developed practice parameters. DEVICES REVIEWED: Three categories of portable monitoring (PM) devices were reviewed with regard to assessing the probability of identifying an apnea-hypopnea index (AHI) of greater or less than 15 in attended and unattended settings. Type 2 (minimum of seven channels, including EEG, EOG, chin EMG, ECG or heart rate, airflow, respiratory effort, oxygen saturation), Type 3 (minimum of four channels, including ventilation or airflow (at least two channels of respiratory movement, or respiratory movement and airflow), heart rate or ECG and oxygen saturation) and Type 4 (most monitors of this type measure a single parameter or two parameters) devices were evaluated, and in-laboratory, attended polysomnography was used as a reference. SPECIFIC RECOMMENDATIONS: (1) Insufficient evidence is available to recommend the use of Type 2 PM devices in attended or unattended settings. (2) Type 3 PM devices appear to be capable of being used in an attended setting to increase or to decrease the probability that a patient has an apnea-hypopnea index greater than 15. (3) The use of Type 3 PM devices in an unattended setting is not recommended to rule in, rule out, or both rule in and rule out a diagnosis of OSA. (4) There is some evidence that the use of Type 3 PM devices in an attended in-laboratory setting may be acceptable to both rule in and rule out a diagnosis of OSA if certain limitations are in place. These limitations include manually scoring the records, using the devices only in patients without significant comorbid conditions, having an awareness that symptomatic patients with a negative study should have a Type 1 study, and not using these devices for titrating positive airway pressure or conducting split-night studies. (5) The use of Type 4 PM devices in attended or unattended settings is not recommended. GENERAL RECOMMENDATIONS: Type 3 and 4 PM devices cannot score sleep and, therefore, do not meet some current Medicare guidelines. The use of PM devices is not recommended for general-population screening or in the absence of a pretest probability of the patient having a diagnosis of OSA, for complaints other than those associated with OSA, without review of raw data during interpretation, by physicians without familiarity with their use and limitations, and without trained personnel to perform technical scoring. Future research should address the use of PM devices in patients with comorbid conditions; non-White patients and women; larger, better-controlled studies; studies focused on the use of Type 2 and 3 devices; studies focusing on decision making and outcomes rather than simple classification using arbitrary cutoffs; and studies that seek to elucidate cost-effectiveness data on the use of PM devices.

Effect of low-frequency magnetic fields on brain electrical activity in human subjects.

OBJECTIVE: To measure the response rate of normal human subjects to a low-strength, low-frequency magnetic field (MF), using nonlinear quantitative analysis of the electroencephalogram (EEG). METHODS: Eight subjects were exposed to a series of trials, each consisting of the application of the MF (1 G, 60 Hz) for 2 s followed by a field-free period of 5 s, and the EEG was analyzed statistically using phase-space methods to assess whether the subject detected the MF. RESULTS: Each subject exhibited statistically significant changes in the EEG during presentation of the MF, as evidenced by increases in percent determinism and percent recurrence, two different measures of deterministic structure in the recorded signal, thereby indicating that the MF had been detected. CONCLUSIONS: The 100% response rate manifested by the study group suggested that the ability to detect low-strength, low-frequency MFs is a common property of the human nervous system.

Restless legs syndrome in the older adult: diagnosis and management.

Restless legs syndrome (RLS) is common in the elderly, with an estimated prevalence of 10 to 35% in individuals over 65 years of age. RLS is characterised by paraesthesias and dysaesthesias of the legs, typically occurring in the evening. The symptoms occur at rest and result in motor restlessness; movement often temporarily relieves the symptoms. Patients with poorly controlled RLS may develop related problems including insomnia (due to sleep-onset restlessness or periodic limb movements or related sleep fragmentation) and depression. RLS can be a primary disorder that develops in the young and includes familial cases. Secondary RLS occurs in association with iron-deficiency anaemia, uraemia and polyneuropathies. Typically, RLS is misdiagnosed or undiagnosed for years. In the elderly, both primary and secondary types of the disorder are common. It is thought that RLS represents lower CNS levels of, or reduced responsiveness to, dopamine. The symptoms improve with dopaminergic therapy. Ergotamine dopamine-receptor agonists such as pergolide, and the non-ergotamine dopamine-receptor agonists pramipexole and ropinirole, are becoming more commonly used to treat RLS. The dopamine precursor levodopa, in combination with carbidopa, is another effective therapeutic agent. An advantage of levodopa is lower cost than non-ergotamine and ergotamine dopamine-receptor agonists. However, the adverse effect of symptom augmentation appears to develop more frequently with levodopa than dopamine-receptor agonists; therefore, levodopa may currently be used somewhat less often as first-line therapy. Patients with painful symptoms may respond favourably to the anticonvulsants gabapentin and carbamazepine. Opioids and hypnosedatives are helpful in selected patients; however, these agents may have troubling adverse effects in the elderly. Correction of iron deficiency improves symptoms in patients with low ferritin levels. Lifestyle modification may also be helpful. Therapy is directed at symptoms, and most symptomatic patients benefit from treatment. It is important to consider RLS in the differential diagnosis of any patient with paraesthesias of the limbs.

MDA and AAEM informational brochures: can patients read them?

The purpose of this study was to assess patient literacy and the readability of patient education brochures from the American Academy of Electrodiagnostic Medicine and Muscular Dystrophy Association. Materials with the appropriate readability and suitability are more likely to provide instruction patients will understand. The readability of the brochure was assessed with Grammatik (Fry, 1977), the literacy of the participants with the Rapid Estimate of Adult Literacy (REALM) in Medicine test, and the suitability of the brochure was tested with the Suitability Assessment of Materials measure (Doak, Doak, & Root, 1993). The average REALM score for participation in this study correlated with a reading level of 7th-8th grade. All six brochures were found to be too difficult for many patients. Readability levels in four of the brochures were at 11th- or 12th-grade levels, one at 9th grade, and one at 10th grade. Materials with readability levels for 9th grade or higher should be rewritten to be understandable by most Americans, or supplemental instruction should be given. Readability and suitability assessments should be made to determine whether educational materials are appropriate for patients.

Manual characterization of sleep spindle index in patients with narcolepsy and idiopathic hypersomnia.

This is a retrospective review of PSG data from 8 narcolepsy patients and 8 idiopathic hypersomnia (IH) patients, evaluating electrophysiologic differences between these two central hypersomnias. Spindles were identified according to the AASM Manual for the Scoring of Sleep and Associated Events; and counted per epoch in the first 50 epochs of N2 sleep and the last 50 epochs of N2 sleep in each patient's PSG. Spindle count data (mean ± standard deviation) per 30 second-epoch (spindle index) in the 8 narcolepsy patients was as follows: 0.37 ± 0.73 for the first 50 epochs of N2; 0.65 ± 1.09 for the last 50 epochs of N2; and 0.51 ± 0.93 for all 100 epochs of N2. Spindle index data in the 8 IH patients was as follows: 2.31 ± 2.23 for the first 50 epochs of N2; 2.84 ± 2.43 for the last 50 epochs of N2; and 2.57 ± 2.35 for all 100 epochs of N2. Intergroup differences in spindle count in the first 50 N2 epochs, the last 50 N2 epochs, and all 100 epochs of scored N2 were significant (P < 0.01) as were the intragroup differences between the first 50 N2 epochs and the last 50 N2 epochs.

Two-group classification of patients with obstructive sleep apnea based on analysis of brain recurrence.

OBJECTIVE: To demonstrate that the severity of obstructive sleep apnea (OSA) could be predicted algorithmically by means of recurrence analysis of the sleep-staged electroencephalogram (EEG). METHODS: A randomly selected cohort of 20 sleep-staged patients with OSA (apnea-hypopnea index (AHI) 5-30) was divided into mild and moderate sub-cohorts (AHI 5-15, 16-30, respectively), and the sleep EEG (C3) was analyzed using analysis of brain recurrence (ABR) (LSU cohort). Twenty distinct but related markers for sleep depth and fragmentation were computed from four ABR variables, and a marker function capable of classifying each patient into one of the two sub-cohorts was determined by linear discriminant analysis. Classification accuracy of individual patients was evaluated using area under the receiver operator characteristics curve (AUROC). As a control procedure, 20 additional sleep-staged patients with OSA whose polysomnographic data was obtained from an independent database were also evaluated (SHHS cohort). RESULTS: On average, markers for sleep depth were reduced and those for sleep fragmentation were increased in the patients with moderate OSA, as expected. All patients in both cohorts were correctly classified using as few as 5-6 markers. SIGNIFICANCE: The degree of severity of OSA was reflected in objective changes in the sleep EEG. Recurrence analysis of the EEG potentially has uses beyond identification of the degree of OSA.